You are using an outdated browser. Please upgrade your browser to improve your experience.

teprotumumab

Ligand Summary
Description
Teprotumumab-trbw’s mechanism of action in patients with Thyroid Eye Disease has not been fully characterized. Teprotumumab-trbw binds to IGF-1R and blocks its activation and signaling
Synonyms & Links
DrugCentral: 5387
LyCHI:  teprotumumab